ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.331,39
-0,25%
S&P 500
5.469,30
0,39%
US Dollar vs BRL
5,4522
0,00%
Bitcoin
0,00000000
0,00%
Brent Oil
84,66
0,56%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. AMEX
  6. Neuraxis Inc (NRXS)

  7. Neuraxis Inc (NRXS) Notícias

NRXS

Neuraxis (NRXS)

Neuraxis Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:NRXS
DataHoraFonteTítuloCódigoCompanhia
07/06/202410:00GlobeNewswire Inc.NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit DisclosureAMEX:NRXSNeuraxis Inc
22/05/202409:00GlobeNewswire Inc.NeurAxis Reports First Quarter 2024 Financial ResultsAMEX:NRXSNeuraxis Inc
21/05/202410:00GlobeNewswire Inc.NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024AMEX:NRXSNeuraxis Inc
20/05/202417:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:NRXSNeuraxis Inc
16/05/202410:00GlobeNewswire Inc.NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in FloridaAMEX:NRXSNeuraxis Inc
15/05/202417:30GlobeNewswire Inc.NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024AMEX:NRXSNeuraxis Inc
15/05/202417:15Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBAMEX:NRXSNeuraxis Inc
23/04/202410:00GlobeNewswire Inc.NeurAxis Announces New Medical Policy Coverage in North DakotaAMEX:NRXSNeuraxis Inc
09/04/202417:05GlobeNewswire Inc.NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsAMEX:NRXSNeuraxis Inc
01/04/202417:15GlobeNewswire Inc.NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024AMEX:NRXSNeuraxis Inc
27/03/202410:00GlobeNewswire Inc.NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center RegistryAMEX:NRXSNeuraxis Inc
11/03/202410:00GlobeNewswire Inc.NeurAxis Announces Highmark BCBS Policy CoverageAMEX:NRXSNeuraxis Inc
11/03/202409:50Edgar (US Regulatory)Form 8-K - Current reportAMEX:NRXSNeuraxis Inc
04/03/202411:00GlobeNewswire Inc.NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy CoverageAMEX:NRXSNeuraxis Inc
27/02/202413:00GlobeNewswire Inc.NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceAMEX:NRXSNeuraxis Inc
20/12/202311:00GlobeNewswire Inc.NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive OfficerAMEX:NRXSNeuraxis Inc
19/12/202319:05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:NRXSNeuraxis Inc
20/11/202319:30GlobeNewswire Inc.NeurAxis Reports Third Quarter 2023 Financial ResultsAMEX:NRXSNeuraxis Inc
15/11/202311:00GlobeNewswire Inc.NeurAxis Announces CareFirst BCBS Policy CoverageAMEX:NRXSNeuraxis Inc
14/11/202311:00GlobeNewswire Inc.NeurAxis Secures $3 Million FinancingAMEX:NRXSNeuraxis Inc
08/11/202311:00GlobeNewswire Inc.NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal DeviceAMEX:NRXSNeuraxis Inc
26/09/202310:00GlobeNewswire Inc.NeurAxis Announces Results of Comparative Study of IB-Stim™ and Standard Medical Therapy in Adolescents with Functional Abdominal Pain DisordersAMEX:NRXSNeuraxis Inc
21/09/202309:00GlobeNewswire Inc.NeurAxis Reports Second Quarter 2023 Financial ResultsAMEX:NRXSNeuraxis Inc
13/09/202317:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:NRXSNeuraxis Inc
13/09/202310:00GlobeNewswire Inc.NeurAxis to Present at the Gilmartin Group Emerging Growth ShowcaseAMEX:NRXSNeuraxis Inc
12/09/202310:00GlobeNewswire Inc.NeurAxis Announces Publication of Prospective Study Showing IB-Stim™ Improves Quality of Life of Adolescents with IBSAMEX:NRXSNeuraxis Inc
29/08/202312:49AllPennyStocks.comNews Brief: NeurAxis Inc.AMEX:NRXSNeuraxis Inc
29/08/202310:00GlobeNewswire Inc.NeurAxis Highlights Pediatric Post-Concussion Clinical StudyAMEX:NRXSNeuraxis Inc
24/08/202310:00GlobeNewswire Inc.NeurAxis Highlights Strength of its Board of DirectorsAMEX:NRXSNeuraxis Inc
22/08/202310:00GlobeNewswire Inc.NeurAxis Highlights Two Independent Studies Showing Benefits of IB-Stim in Adolescents Involving the Gut MicrobiomeAMEX:NRXSNeuraxis Inc
 Apresentando as notícias mais relevantes sobre:AMEX:NRXS

Seu Histórico Recente

BMF
CCMU25
CCMU25 - Setembro 2025
COIN
BUSDEETH
TG
MKO
Michael Kors
NYSE
KTB
Kontoor Brands
USOTC
NMSCA
Nutrition Management Ser... (CE)
LSE
SJPY
Wt S Jpy L Usd
AMEX
FSMB
First Trust Short Durati...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados